BCL2 and melanoma: In BRAF-mutant SK-MEL-3 melanoma cells, the natural HDAC inhibitor trichostatin A downregulated pro-apoptotic p53 and anti-apoptotic Bcl-2 at low doses in line with a favored cell cycle arrest instead of apoptosis induction.